Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SNES files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSenesTech appoints Michael Edell as CEO with $360K salary and 5% equity grant
Filed May 7, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
high
Michael Edell, 62, appointed President and CEO effective May 6, 2026, replacing Joel Fruendt. Edell previously served as Interim COO since October 2025 and founded multiple consumer goods companies.
Item 5.02 verify on EDGAR → -
high
Edell granted stock options representing 5% of outstanding shares, vesting quarterly over three years. Exercise requires shareholder approval to increase shares under 2018 plan, representing significant potential dilution.
Item 5.02 verify on EDGAR → -
medium
New CEO receives $360,000 base salary plus 60% target bonus ($216,000). If terminated without cause, entitled to 6-12 months severance, healthcare costs, full option vesting, and prorated bonus.
Item 5.02 verify on EDGAR → -
low
Edell simultaneously appointed to Board as Class III director with term through 2028 annual meeting. Board must nominate him for re-election while he serves as CEO.
Item 5.02 verify on EDGAR →
Summary
SenesTech installed new leadership on May 6, 2026, appointing Michael Edell as President and CEO. The 62-year-old executive transitions from his interim COO role, which he held since October 2025, and brings entrepreneurial experience from founding consumer goods companies including Westlake Serial Company and MaddieBrit Products.
Retail investors should note the substantial equity component of Edell's compensation package. The 5% stock option grant represents meaningful potential dilution and cannot be exercised until shareholders approve expanding the 2018 Equity Incentive Plan's share reserve. Combined with his $360,000 salary and 60% target bonus, the package reflects the board's commitment to the new leadership direction.
The generous severance terms—including full option acceleration upon termination without cause—provide Edell significant downside protection. Watch for the upcoming shareholder vote on expanding the equity plan, which will determine whether Edell can exercise his options. Also monitor whether the leadership change translates into operational improvements or strategic shifts, particularly given Edell's consumer products background in a pest control technology company.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Mr. Edell was granted an option to purchase 5.0% of the outstanding shares of the Company’s common stock (the “Option”). The Option is scheduled to vest over a three-year period commencing on May 1, 2026, with 1/12th of the shares subject to the Option vesting on the last day of each calendar quarter, subject to Mr. Edell’s continuous service through the applicable vesting date.
Edell received a stock option grant representing 5.0% of outstanding shares, vesting quarterly over three years starting May 1, 2026. The option cannot be exercised until shareholders approve an increase in shares reserved under the 2018 Equity Incentive Plan, representing significant potential dilution.
Added in current filing · verify on EDGAR →
In the event of Mr. Edell’s termination by the Company without Cause or his resignation for Good Reason (as such terms are defined in the Employment Agreement), Mr. Edell will be eligible to receive (i) severance benefits equal to six months’ continuation of his then-current base salary, plus one additional month for every completed year of service to the Company after the Commencement Date, up to a maximum of 12 months (the “Severance Period”); (ii) reimbursement of healthcare insurance costs during the Severance Period; (iii) full vesting of the Option; and (iv) a pro-rated Annual Bonus for the year of termination based on actual performance.
If terminated without cause or if Edell resigns for good reason, he receives 6-12 months base salary continuation, healthcare reimbursement, full acceleration of his 5% stock option, and prorated bonus. This represents substantial protection and potential cost to the company.
Event · Item 9.01 — Financial Statements and Exhibits
SenesTech disclosed an employment agreement with Michael Edell dated May 6, 2026.
Added in current filing · verify on EDGAR →
Employment Letter Agreement between SenesTech, Inc. and Michael Edell dated May 6, 2026
The company entered into an employment letter agreement with Michael Edell on May 6, 2026. The 8-K does not disclose the role, compensation, or other terms of this employment arrangement within the filing body itself, only listing the agreement as an exhibit.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify